Table 4. Plasmids available for transgene expression using the one-promoter system.
Plasmida | Promoterb | Upstream Genec | Selectable Markerd |
---|---|---|---|
pMO449e | HSP70A/RBCS2 | CrVENUS-3FLAG | APHVIII |
pMO470e | HSP70A/RBCS2 | CrVENUS-3FLAG | APHVIII |
pMO471e | HSP70A/RBCS2 | CrVENUS-3FLAG | APHVIII |
pMO488 | HSP70A/RBCS2 | CrVENUS | APHVIII |
pMO490 | HSP70A/RBCS2 | sfGFP-3FLAG | APHVIII |
pMO519 | HSP70A/RBCS2 | CrmCHERRY | APHVIII |
pMO520 | HSP70A/RBCS2 | CrmCHERRY-3FLAG | APHVIII |
pMO507 | PSAD | CrVENUS-3FLAG | APHVIII |
pMO508 | TUB2 | CrVENUS-3FLAG | APHVIII |
pMO561f | TUB2 | CrVENUS-3FLAG | APHVIII |
Available plasmids with one-promoter expression constructs of the general structure shown in Figure 1B.
Except as indicated in note f, all promoters are followed by the first three codons and intron of RBCS2.
All genes indicated have been codon optimized for Chlamydomonas. These genes can be replaced in toto by HpaI–StuI fragments containing other GOIs whose expression/overexpression is desired. Fluorescence tagging of a gene product of interest can be achieved by inserting the coding sequence, in frame, at the HpaI site (C-terminal tagging) or the StuI site (N-terminal tagging).
Other selectable markers could be inserted as NdeI–BamHI fragments. To date, however, we have not had success with selectable markers other than APHVIII (see text).
These plasmids differ only in the short linker between CrVENUS-3FLAG and APHVIII (see Figure 2D and Table 2).
Same as pMO508 except that the RBCS2 ATG start codon has been changed to TTG. This allowed expression of CrVENUS-3FLAG, presumably from its own start codon (i.e., without the additional amino acids from RBCS2).